Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum

Schuuring, Mark Johan; Treskes, Roderick Willem; Castiello, Teresa; Jensen, Magnus Thorsten; Casado-Arroyo, Ruben; Neubeck, Lis; Lyon, Alexander R; Keser, Nurgul; Rucinski, Marcin; Marketou, Maria; Lambrinou, Ekaterini; Volterrani, Maurizio; Hill, Loreena

Abstract

The 2021 European Society of Cardiology guideline on diagnosis and treatment of acute and chronic heart failure (HF) and the 2023 Focused Update include recommendations on the pharmacotherapy for patients with New York Heart Association (NYHA) class II–IV HF with reduced ejection fraction. However, multinational data from the EVOLUTION HF study found substantial prescribing inertia of guideline-directed medical therapy (GDMT) in clinical practice. The cause was multifactorial and included limitations in organizational resources. Digital solutions like digital consultation, digital remote monitoring, digital interrogation of cardiac implantable electronic devices, clinical decision support systems, and multifaceted interventions are increasingly available worldwide. The objectives of this Clinical Consensus Statement are to provide (i) examples of digital solutions that can aid the optimization of prescription of GDMT, (ii) evidence-based insights on the optimization of prescription of GDMT using digital solutions, (iii) current evidence gaps and implementation barriers that limit the adoption of digital solutions in clinical practice, and (iv) critically discuss strategies to achieve equality of access, with reference to patient subgroups. Embracing digital solutions through the use of digital consults and digital remote monitoring will future-proof, for example alerts to clinicians, informing them of patients on suboptimal GDMT. Researchers should consider employing multifaceted digital solutions to optimize effectiveness and use study designs that fit the unique sociotechnical aspects of digital solutions. Artificial intelligence solutions can handle larger data sets and relieve medical professionals’ workloads, but as the data on the use of artificial intelligence in HF are limited, further investigation is warranted.

Citation

Schuuring, M. J., Treskes, R. W., Castiello, T., Jensen, M. T., Casado-Arroyo, R., Neubeck, L., Lyon, A. R., Keser, N., Rucinski, M., Marketou, M., Lambrinou, E., Volterrani, M., & Hill, L. (2024). Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum. European Heart Journal – Digital Health, 5(6), 670-682. https://doi.org/10.1093/ehjdh/ztae064

• Journal Article Type: Article
• Acceptance Date: Aug 13, 2024
• Online Publication Date: Aug 30, 2024
• Publication Date: 2024-11
• Deposit Date: Sep 9, 2024
• Publicly Available Date: Sep 9, 2024
• Journal: European Heart Journal - Digital Health
• Print ISSN: 2634-3916
• Electronic ISSN: 2634-3916
• Publisher: Oxford University Press
• Peer Reviewed: Peer Reviewed
• Volume: 5
• Issue: 6
• Pages: 670-682
• DOI: https://doi.org/10.1093/ehjdh/ztae064
• Keywords: Digital health, Heart failure, GDMT, Up-titration, Remote contact, Pharmacotherapy